Macular Degeneration

Showing NaN - NaN of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Geographic Atrophy Insights (i-GAIN) Natural History Study

Recruiting
  • Dry Age-related Macular Degeneration
  • +6 more
    • Belfast, United Kingdom
    • +11 more
    Mar 22, 2023

    Macular Degeneration Trial in United Kingdom, United States (BI 754132)

    Terminated
    • Macular Degeneration
    • BI 754132
    • Beverly Hills, California
    • +12 more
    Aug 23, 2022

    Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)

    Recruiting
    • Macular Degeneration
    • Geographic Atrophy
    • Phoenix, Arizona
    • +83 more
    Aug 19, 2022

    Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease Trial in United Kingdom, United States (GT005)

    Recruiting
    • Dry Age-related Macular Degeneration
    • +6 more
    • GT005
    • Saint Petersburg, Florida
    • +12 more
    Dec 21, 2021

    Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

    Active, not recruiting
    • Geographic Atrophy
    • Macular Degeneration
    • Beverly Hills, California
    • +208 more
    Sep 14, 2021

    Macular Degeneration Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

    Completed
    • Macular Degeneration
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Wien, Austria
    • +70 more
    Jun 1, 2021

    Natural Progression of Dry Age-related Macular Degeneration

    Recruiting
    • Dry Age-related Macular Degeneration
    • +5 more
      • Phoenix, Arizona
      • +65 more
      Feb 22, 2021

      Macular Degeneration Trial in United Kingdom (Epimacular Brachytherapy, Ranibizumab)

      Completed
      • Macular Degeneration
      • Exeter, Devon, United Kingdom
      • +23 more
      Nov 23, 2020

      Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)

      Completed
      • Macular Degeneration
      • Abicipar Pegol
      • +2 more
      • Birmingham, Alabama
      • +186 more
      Jul 17, 2020

      Macular Degeneration Trial in Worldwide (Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321))

      Completed
      • Macular Degeneration
      • Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)
      • Strathfield, New South Wales, Australia
      • +38 more
      May 12, 2020

      Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)

      Terminated
      • Geographic Atrophy
      • Macular Degeneration
      • 400 µg Brimonidine Implant
      • Sham
      • Phoenix, Arizona
      • +40 more
      Mar 29, 2019

      Macular Degeneration Trial in Worldwide (pazopanib eye drops, , ranibizumab intravitreal injection)

      Completed
      • Macular Degeneration
      • pazopanib eye drops
      • +2 more
      • Peoria, Arizona
      • +76 more
      Dec 7, 2017

      Macular Degeneration Trial in United Kingdom, United States (RO6867461)

      Completed
      • Macular Degeneration
      • Colorado Springs, Colorado
      • +7 more
      Nov 1, 2016

      Macular Degeneration Trial in Worldwide (Regorafenib, ophthalmic oily suspension (BAY73-4506), Sham IVT, Ranibizumab)

      Terminated
      • Macular Degeneration
      • Regorafenib, ophthalmic oily suspension (BAY73-4506)
      • +3 more
      • Tucson, Arizona
      • +148 more
      Jul 25, 2016

      Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321))

      Completed
      • Macular Degeneration
      • Ranibizumab
      • Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
      • Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina
      • +188 more
      Nov 28, 2014

      AMD, Wet AMD, Age-Related Macular Degeneration Trial in Worldwide (IRay)

      Completed
      • AMD
      • +6 more
      • IRay
      • Graz, Austria
      • +20 more
      Dec 1, 2014

      Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))

      Completed
      • Macular Degeneration
      • ranibizumab
      • aflibercept injection (VEGF Trap-Eye, BAY86-5321)
      • Birmingham, Alabama
      • +187 more
      Dec 20, 2012

      Age Related Macular Degeneration (AMD), Macular Degeneration, Choroidal Neovascularization (CNV) Trial in Worldwide (Pegaptanib

      Terminated
      • Age Related Macular Degeneration (AMD)
      • +2 more
      • Pegaptanib Sodium 0.3 mg
      • Graz, Austria
      • +57 more
      Apr 2, 2012

      Wet Age-related Macular Degeneration, Age-related Macular Degeneration, AMD Trial in Milan, London, Manchester (IRay)

      Withdrawn
      • Wet Age-related Macular Degeneration
      • +4 more
      • IRay
      • Milan, Italy
      • +2 more
      Dec 28, 2011

      Macular Degeneration Trial in Worldwide (Epi-Rad90™ Ophthalmic System, ranibizumab)

      Unknown status
      • Macular Degeneration
      • Phoenix, Arizona
      • +31 more
      Jul 26, 2011

      Choroidal Neovascularization, Macular Degeneration Trial in Canada, United States (verteporfin, ranibizumab, dexamethasone)

      Completed
      • Choroidal Neovascularization
      • Macular Degeneration
      • Mobile, Alabama
      • +25 more
      May 31, 2011

      Macular Degeneration, Choroidal Neovascularization Trial in Canada, United States (Verteporfin Photodynamic Therapy,

      Completed
      • Macular Degeneration
      • Choroidal Neovascularization
      • Verteporfin Photodynamic Therapy
      • +3 more
      • Tucson, Arizona
      • +42 more
      Mar 23, 2011